Contrary to old beliefs, a new study suggests daily coffee might help manage irregular heart rhythms like AFib. Researchers ...

Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the ...

Irregular heartbeats can signal AFib. Early detection and appropriate treatments help manage it and protect long-term heart health.

Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) ...

Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...

Pirtobrutinib showed noninferiority in ORR compared to ibrutinib in BTK inhibitor-naive CLL/SLL patients, with a favorable PFS trend. Safety profiles indicated fewer adverse events with pirtobrutinib, ...

Studies show clear links between dental health and heart disease. Brush up on ideal oral hygiene habits (and the surprising ...

Noncovalent Bruton tyrosine kinase inhibitors like pirtobrutinib may be a more effective first-line therapy for chronic ...

A clinical trial found that Jaypirca was more effective than Imbruvica across the frontline and relapsed/refractory CLL/SLL settings.

Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms of overall response rate in the first head-to-head comparison with ibrutinib ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...

Boston Scientific faces intense competition from major players such as Medtronic, Johnson & Johnson, and Abbott Laboratories.